Apoptosis repressor with caspase recruitment domain, a multifunctional modulator of cell death

Journal of Cellular and Molecular Medicine

Volumn 15, Issue 5, 2011, Pages 1044-1053

  Ludwig Galezowska, Agnieszka H ^a   Flanagan, Lorna ^a   Rehm, Markus ^a  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

Author keywords

Apoptosis; Apoptosis repressor with caspase recruitment domain (ARC); Bax; Cancer; Cardiophysiology; Caspases; Cell death

Indexed keywords

APOPTOSIS REGULATORY PROTEIN; CASPASE; DEATH RECEPTOR;

ANIMAL; ANTIBODY SPECIFICITY; APOPTOSIS; CHEMISTRY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; REVIEW;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CASPASES; GENE EXPRESSION REGULATION; HUMANS; ORGAN SPECIFICITY; RECEPTORS, DEATH DOMAIN;

EID: 79957590101     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2010.01221.x     Document Type: Review

References (60)

1. Koseki T, Inohara N, Chen S, et al ARC, an inhibitor of apoptosis expressed in skeletal muscle and heart that interacts selectively with caspases. Proc Natl Acad Sci USA. 1998; 95: 5156-60.
2. Stoss O, Schwaiger FW, Cooper TA, et al Alternative splicing determines the intracellular localization of the novel nuclear protein Nop30 and its interaction with the splicing factor SRp30c. J Biol Chem. 1999; 274: 10951-62.
3. Geertman R, McMahon A, Sabban EL. Cloning and characterization of cDNAs for novel proteins with glutamic acid-proline dipeptide tandem repeats. Biochim Biophys Acta. 1996; 1306: 147-52.
4. Abmayr S, Crawford RW, Chamberlain JS. Characterization of ARC, apoptosis repressor interacting with CARD, in normal and dystrophin-deficient skeletal muscle. Hum Mol Genet. 2004; 13: 213-21.
5. Ekhterae D, Hinmon R, Matsuzaki K, et al Infarction induced myocardial apoptosis and ARC activation. J Surg Res. 2011; 166: 59-67.
6. Engidawork E, Gulesserian T, Yoo BC, et al Alteration of caspases and apoptosis-related proteins in brains of patients with Alzheimer's disease. Biochem Biophys Res Commun. 2001; 281: 84-93.
7. Donath S, Li P, Willenbockel C, et al Apoptosis repressor with caspase recruitment domain is required for cardioprotection in response to biomechanical and ischemic stress. Circulation. 2006; 113: 1203-12.
8. Mercier I, Vuolo M, Jasmin JF, et al ARC (apoptosis repressor with caspase recruitment domain) is a novel marker of human colon cancer. Cell Cycle. 2008; 7: 1640-7.
9. Wang M, Qanungo S, Crow MT, et al Apoptosis repressor with caspase recruitment domain (ARC) is expressed in cancer cells and localizes to nuclei. FEBS Lett. 2005; 579: 2411-5.
10. Sasson R, Rimon E, Dantes A, et al Gonadotrophin-induced gene regulation in human granulosa cells obtained from IVF patients. Modulation of steroidogenic genes, cytoskeletal genes and genes coding for apoptotic signalling and protein kinases. Mol Hum Reprod. 2004; 10: 299-311.
11. Nam YJ, Mani K, Ashton AW, et al Inhibition of both the extrinsic and intrinsic death pathways through nonhomotypic death-fold interactions. Mol Cell. 2004; 15: 901-12.
12. Pyo JO, Nah J, Kim HJ, et al Protection of cardiomyocytes from ischemic/hypoxic cell deathviaDrbp1 and pMe2GlyDH in cardio-specific ARC transgenic mice. J Biol Chem. 2008; 283: 30707-14.
13. Ekhterae D, Lin Z, Lundberg MS, et al ARC inhibits cytochrome c release from mitochondria and protects against hypoxia-induced apoptosis in heart-derived H9c2 cells. Circ Res. 1999; 85: e70-7.
14. Li PF, Li J, Muller EC, et al Phosphorylation by protein kinase CK2: a signaling switch for the caspase-inhibiting protein ARC. Mol Cell. 2002; 10: 247-58.
15. Dowds TA, Sabban EL. Endogenous and exogenous ARC in serum withdrawal mediated PC12 cell apoptosis: a new pro-apoptotic role for ARC. Cell Death Differ. 2001; 8: 640-8.
16. Quadrilatero J, Bloemberg D. Apoptosis repressor with caspase recruitment domain is dramatically reduced in cardiac, skeletal, and vascular smooth muscle during hypertension. Biochem Biophys Res Commun. 2010; 391: 1437-42.
17. Neuss M, Monticone R, Lundberg MS, et al The apoptotic regulatory protein ARC (apoptosis repressor with caspase recruitment domain) prevents oxidant stress-mediated cell death by preserving mitochondrial function. J Biol Chem. 2001; 276: 33915-22.
18. Tinel A, Tschopp J. The PIDDosome, a protein complex implicated in activation of caspase-2 in response to genotoxic stress. Science. 2004; 304: 843-6.
19. Zou H, Li Y, Liu X, et al An APAF-1.cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J Biol Chem. 1999; 274: 11549-56.
20. Jo DG, Jun JI, Chang JW, et al Calcium binding of ARC mediates regulation of caspase 8 and cell death. Mol Cell Biol. 2004; 24: 9763-70.
21. Tan WQ, Wang JX, Lin ZQ, et al Novel cardiac apoptotic pathway: the dephosphorylation of apoptosis repressor with caspase recruitment domain by calcineurin. Circulation. 2008; 118: 2268-76.
22. Foo RS, Chan LK, Kitsis RN, et al Ubiquitination and degradation of the anti-apoptotic protein ARC by MDM2. J Biol Chem. 2007; 282: 5529-35.
23. Nam YJ, Mani K, Wu L, et al The apoptosis inhibitor ARC undergoes ubiquitin-proteasomal-mediated degradation in response to death stimuli: identification of a degradation-resistant mutant. J Biol Chem. 2007; 282: 5522-8.
24. Foo RS, Nam YJ, Ostreicher MJ, et al Regulation of p53 tetramerization and nuclear export by ARC. Proc Natl Acad Sci USA. 2007; 104: 20826-31.
25. Siu PM, Bryner RW, Murlasits Z, et al Response of XIAP, ARC, and FLIP apoptotic suppressors to 8 wk of treadmill running in rat heart and skeletal muscle. J Appl Physiol. 2005; 99: 204-9.
26. Quadrilatero J, Rush JW. Increased DNA fragmentation and altered apoptotic protein levels in skeletal muscle of spontaneously hypertensive rats. J Appl Physiol. 2006; 101: 1149-61.
27. Quadrilatero J, Rush JW. Evidence for a pro-apoptotic phenotype in skeletal muscle of hypertensive rats. Biochem Biophys Res Commun. 2008; 368: 168-74.
28. Li Y, Ge X, Liu X. The cardioprotective effect of postconditioning is mediated by ARC through inhibiting mitochondrial apoptotic pathway. Apoptosis. 2009; 14: 164-72.
29. Bouma W, Noma M, Kanemoto S, et al Sex-related resistance to myocardial ischemia-reperfusion injury is associated with high constitutive ARC expression. Am J Physiol Heart Circ Physiol. 2010; 298: H1510-7.
30. Shelke RR, Leeuwenburgh C. Lifelong caloric restriction increases expression of apoptosis repressor with a caspase recruitment domain (ARC) in the brain. FASEB J. 2003; 17: 494-6.
31. Ren J, Babcock SA, Li Q, et al Aldehyde dehydrogenase-2 transgene ameliorates chronic alcohol ingestion-induced apoptosis in cerebral cortex. Toxicol Lett. 2009; 187: 149-56.
32. Dirks AJ, Leeuwenburgh C. Aging and lifelong calorie restriction result in adaptations of skeletal muscle apoptosis repressor, apoptosis-inducing factor, X-linked inhibitor of apoptosis, caspase-3, and caspase-12. Free Radic Biol Med. 2004; 36: 27-39.
33. Mercier I, Vuolo M, Madan R, et al ARC, an apoptosis suppressor limited to terminally differentiated cells, is induced in human breast cancer and confers chemo- and radiation-resistance. Cell Death Differ. 2005; 12: 682-6.
34. Chen LH, Jiang CC, Watts R, et al Inhibition of endoplasmic reticulum stress-induced apoptosis of melanoma cells by the ARC protein. Cancer Res. 2008; 68: 834-42.
35. Wu L, Nam YJ, Kung G, et al Induction of the apoptosis inhibitor ARC by Ras in human cancers. J Biol Chem. 2010; 285: 19235-45.
36. Li YZ, Lu DY, Tan WQ, et al p53 initiates apoptosis by transcriptionally targeting the antiapoptotic protein ARC. Mol Cell Biol. 2008; 28: 564-74.
37. Yu J, Zhang L. PUMA, a potent killer with or without p53. Oncogene. 2008; 27: S71-83.
38. Haupt Y, Maya R, Kazaz A, et al Mdm2 promotes the rapid degradation of p53. Nature. 1997; 387: 296-9.
39. Kubbutat MH, Jones SN, Vousden KH. Regulation of p53 stability by Mdm2. Nature. 1997; 387: 299-303.
40. Gonzalvez F, Schug ZT, Houtkooper RH, et al Cardiolipin provides an essential activating platform for caspase-8 on mitochondria. J Cell Biol. 2008; 183: 681-96.
41. Murtaza I, Wang HX, Feng X, et al Down-regulation of catalase and oxidative modification of protein kinase CK2 lead to the failure of apoptosis repressor with caspase recruitment domain to inhibit cardiomyocyte hypertrophy. J Biol Chem. 2008; 283: 5996-6004.
42. Izeradjene K, Douglas L, Tillman DM, et al Reactive oxygen species regulate caspase activation in tumor necrosis factor-related apoptosis-inducing ligand-resistant human colon carcinoma cell lines. Cancer Res. 2005; 65: 7436-45.
43. Lavrik IN, Golks A, Baumann S, et al Caspase-2 is activated at the CD95 death-inducing signaling complex in the course of CD95-induced apoptosis. Blood. 2006; 108: 559-65.
44. Olsson M, Vakifahmetoglu H, Abruzzo PM, et al DISC-mediated activation of caspase-2 in DNA damage-induced apoptosis. Oncogene. 2009; 28: 1949-59.
45. Danial NN. BAD: undertaker by night, candyman by day. Oncogene. 2008; 27: S53-70.
46. Johnstone RW, Frew AJ, Smyth MJ. The TRAIL apoptotic pathway in cancer onset, progression and therapy. Nat Rev Cancer. 2008; 8: 782-98.
47. Brenner D, Mak TW. Mitochondrial cell death effectors. Curr Opin Cell Biol. 2009; 21: 871-7.
48. Wei MC, Zong WX, Cheng EH, et al Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science. 2001; 292: 727-30.
49. Li P, Nijhawan D, Budihardjo I, et al Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell. 1997; 91: 479-89.
50. Du C, Fang M, Li Y, et al Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell. 2000; 102: 33-42.
51. Zha J, Harada H, Yang E, et al Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L). Cell. 1996; 87: 619-28.
52. Yamane K, Kinsella TJ. CK2 inhibits apoptosis and changes its cellular localization following ionizing radiation. Cancer Res. 2005; 65: 4362-7.
53. An J, Li P, Li J, et al ARC is a critical cardiomyocyte survival switch in doxorubicin cardiotoxicity. J Mol Med. 2009; 87: 401-10.
54. Wang JX, Li Q, Li PF. Apoptosis repressor with caspase recruitment domain contributes to chemotherapy resistance by abolishing mitochondrial fission mediated by dynamin-related protein-1. Cancer Res. 2009; 69: 492-500.
55. Gustafsson AB, Tsai JG, Logue SE, et al Apoptosis repressor with caspase recruitment domain protects against cell death by interfering with Bax activation. J Biol Chem. 2004; 279: 21233-8.
56. Chipuk JE, Bouchier-Hayes L, Kuwana T, et al PUMA couples the nuclear and cytoplasmic proapoptotic function of p53. Science. 2005; 309: 1732-5.
57. Chipuk JE, Kuwana T, Bouchier-Hayes L, et al Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science. 2004; 303: 1010-4.
58. Sheridan C, Delivani P, Cullen SP, et al Bax- or Bak-induced mitochondrial fission can be uncoupled from cytochrome c release. Mol Cell. 2008; 31: 570-85.
59. Li J, Li Y, Qin D, et al Mitochondrial fission leads to Smac/DIABLO release quenched by ARC. Apoptosis. 2010; 15: 1187-96.
60. Kitano H. Biological robustness. Nat Rev Genet. 2004; 5: 826-37.